Representing Arizona, Colorado, Montana and Utah, the Colorado BioScience Association (CBSA) will attract leading investors, executives and representatives to the 2015 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) at the Vail Marriott Mountain Resort in Lionshead. From September 23-24, thirty selected companies will discuss current trends and innovations in the biotechnology industry.
“The Rocky Mountain region is the largest and most advanced area for bioscience between the two coasts,” said April Giles, President and CEO of CBSA. “Colorado ranks in the top 10 among states for venture capital investment in the life sciences, garnering more than $1.2 billion in financing and investments from 2011-2013.”
Selected out of 60 companies by the Rocky Mountain Life Sciences Investor and Partnering Conference selection committee, all 30 presenting companies offer innovative pharmaceuticals, medical devices, therapies and technologies. “It’s an honor to connect innovators with resources to accelerate industry growth in our dynamic region,” said Giles.
